{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:27:32Z","timestamp":1783643252052,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.4158\/ep15704.or","type":"journal-article","created":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T11:47:31Z","timestamp":1446464851000},"page":"294-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Primary Hyperparathyroidism, With A Focus On Management Of The Normocalcemic Form: To Treat Or Not To Treat?"],"prefix":"10.1016","volume":"22","author":[{"given":"Helena","family":"\u0160iprov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zden\u011bk","family":"Fry\u0161\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Sou\u010dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP15704.OR_bb0010","series-title":"Parathyroid Glands: Regulation, Role in Human Disease and Indications for Surgery","author":"Ashford","year":"2014"},{"key":"10.4158\/EP15704.OR_bb0015","series-title":"Endocrine Secrets","author":"McDermott","year":"2009"},{"key":"10.4158\/EP15704.OR_bb0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/CCO.0b013e32834c2fb9","article-title":"A summary of the new phenomenon of normocalcemic hyperparathyroidism and appropriate management","volume":"24","author":"Carneiro-Pla","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"10.4158\/EP15704.OR_bb0025","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15704.OR_bb0030","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1210\/jc.2014-1415","article-title":"Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Silverberg","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15704.OR_bb0035","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1210\/jc.2013-1300","article-title":"Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations","volume":"98","author":"Cusano","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15704.OR_bb0040","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Eastell","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15704.OR_bb0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0039-6060(97)90357-3","article-title":"Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women","volume":"121","author":"Lundgren","year":"1997","journal-title":"Surgery"},{"key":"10.4158\/EP15704.OR_bb0050","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s12020-012-9694-z","article-title":"Normocalcemic primary hyperparathyroidism: one-year follow-up in one hundred postmenopausal women","volume":"42","author":"Garc\u00eda-Mart\u00edn","year":"2012","journal-title":"Endocrine"},{"key":"10.4158\/EP15704.OR_bb0055","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1590\/S0004-27302011000500003","article-title":"Normocalcemic primary hyperparathyroidism in clinical practice: an indolent condition or a silent threat?","volume":"55","author":"Marques","year":"2011","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.4158\/EP15704.OR_bb0060","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1210\/jc.2003-031014","article-title":"\u201cIncipient\u201d primary hyperparathyroidism: a \u201cforme fruste\u201d of an old disease","volume":"88","author":"Silverberg","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15704.OR_bb0065","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2006-2802","article-title":"Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype","volume":"92","author":"Lowe","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15704.OR_bb0070","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1590\/S0004-27302010000200004","article-title":"Normocalcemic primary hyperparathyroidism","volume":"54","author":"Bilezikian","year":"2010","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.4158\/EP15704.OR_bb0075","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.amjmed.2004.06.037","article-title":"Characterization of normocalcemic primary hyperparathyroidism","volume":"117","author":"Tordjman","year":"2004","journal-title":"Am J Med"},{"key":"10.4158\/EP15704.OR_bb0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jocd.2012.11.005","article-title":"Asymptomatic primary hyperparathyroidism","volume":"16","author":"Silverberg","year":"2013","journal-title":"J Clin Densitom"},{"key":"10.4158\/EP15704.OR_bb0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jocd.2012.12.001","article-title":"Normocalcemic primary hyperparathyroidism","volume":"16","author":"Cusano","year":"2013","journal-title":"J Clin Densitom"},{"key":"10.4158\/EP15704.OR_bb0090","doi-asserted-by":"crossref","first-page":"390","DOI":"10.14310\/horm.2002.1370","article-title":"Normocalcemic primary hyperparathyroidism: a newly emerging disease needing therapeutic intervention","volume":"11","author":"D\u00edaz-Soto","year":"2012","journal-title":"Hormones (Athens)"},{"key":"10.4158\/EP15704.OR_bb0095","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00268-012-1438-y","article-title":"Surgical management of normocalcemic primary hyperparathyroidism","volume":"36","author":"Wade","year":"2012","journal-title":"World J Surg"},{"key":"10.4158\/EP15704.OR_bb0100","doi-asserted-by":"crossref","first-page":"128352","DOI":"10.1155\/2012\/128352","article-title":"Normocalcemic versus hypercalcemic primary hyperparathyroidism: more stone than bone?","volume":"2012","author":"Amaral","year":"2012","journal-title":"J Osteoporos"},{"key":"10.4158\/EP15704.OR_bb0105","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4158\/EP14074.OR","article-title":"Silent renal stones in primary hyperparathyroidism: prevalence and clinical features","volume":"20","author":"Cassibba","year":"2014","journal-title":"Endocr Pract"},{"key":"10.4158\/EP15704.OR_bb0110","doi-asserted-by":"crossref","first-page":"112","DOI":"10.14712\/23362936.2015.50","article-title":"Changes in the pattern of primary hyperparathyroidism in Czech Republic","volume":"116","author":"Broul\u00edk","year":"2015","journal-title":"Prague Med Rep"},{"key":"10.4158\/EP15704.OR_bb0115","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1530\/EJE-09-1067","article-title":"Cardiovascular risk factors and arterial rigidity in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism","volume":"162","author":"Tordjman","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP15704.OR_bb0120","article-title":"Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism","author":"Tuna","year":"2015","journal-title":"J Bone Miner Metab"},{"key":"10.4158\/EP15704.OR_bb0125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1530\/EJE-12-0124","article-title":"Effect of parathyroidectomy on subclinical cardiovascular disease in mild primary hyperparathyroidism","volume":"167","author":"Walker","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP15704.OR_bb0130","doi-asserted-by":"crossref","first-page":"408295","DOI":"10.1155\/2012\/408295","article-title":"Arterial hypertension, metabolic syndrome and subclinical cardiovascular organ damage in patients with asymptomatic primary hyperparathyroidism before and after parathyroidectomy: preliminary results","volume":"2012","author":"Luigi","year":"2012","journal-title":"Int J Endocrinol"},{"key":"10.4158\/EP15704.OR_bb0135","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1210\/jc.2014-4432","article-title":"Is normocalcemic primary hyperparathyroidism harfmul or harmless?","volume":"100","author":"Chen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15704.OR_bb0140","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/dmrr.637","article-title":"Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy","volume":"23","author":"Khaleeli","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"key":"10.4158\/EP15704.OR_bb0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4158\/EP.14.1.69","article-title":"Prevalence of type 2 diabetes mellitus in patients with primary hyperparathyroidism","volume":"14","author":"Cardenas","year":"2008","journal-title":"Endocr Pract"},{"key":"10.4158\/EP15704.OR_bb0150","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s12020-012-9627-x","article-title":"Investigation of insulin resistance in patients with normocalcemic primary hyperparathyroidism","volume":"42","author":"Cakir","year":"2012","journal-title":"Endocrine"},{"key":"10.4158\/EP15704.OR_bb0155","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12020-012-9674-3","article-title":"Glucose intolerance and primary hyperparathyroidism: an unresolved relationship","volume":"42","author":"Rubin","year":"2012","journal-title":"Endocrine"},{"key":"10.4158\/EP15704.OR_bb0160","series-title":"Diabetes Secondary to Endocrine and Pancreatic Disorders","first-page":"92","article-title":"Diabetes in hyperparathyroidism","author":"Thomas","year":"2014"},{"key":"10.4158\/EP15704.OR_bb0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4158\/EP14195.OR","article-title":"Normocalcemic hyperparathyroidism and insulin resistence","volume":"21","author":"Temizkan","year":"2015","journal-title":"Endocr Pract"},{"key":"10.4158\/EP15704.OR_bb0170","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1210\/jc.2013-1518","article-title":"Bone mineral density evolution after succesful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism","volume":"98","author":"Koumakis","year":"2013","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20359590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20359590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:59:55Z","timestamp":1761515995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20359590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1530891X20359590"],"URL":"https:\/\/doi.org\/10.4158\/ep15704.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Hyperparathyroidism, With A Focus On Management Of The Normocalcemic Form: To Treat Or Not To Treat?","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP15704.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}